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Abstract
Prostate cancer (PCa) disproportionately affects African
American men. Early detection reduces risk of mortality. The
United States Preventive Services Task Force (USPSTF) issued
an updated recommendation statement on serum Prostate
Specific Antigen (PSA)-based screening for PCa. Specifically, in
2012, the USPSTF recommended against PSA-based screening
due to risk for overdiagnosis and overtreatment. However, the
updated 2018 guidelines recommend consideration of screening
for certain at risk men and revised the recommendation rating
from “D” to “C.” This new guideline recommends providers to
educate high-risk men on the benefits and harms of PSA-based
PCa screening so that they can make an informed decision. The
Affordable Care Act (ACA) includes provisions of service coverage
for patient navigators who can help patients decide whether
screening is appropriate, given potential risks and benefits, and
training of health care providers in shared-decision regarding
screening/treatment. These services can be utilized to support
health care providers to better adhere to the new guideline.
However, recommendations that are given a C rating or lower
are not consistently reimbursed through many plans, including
those offered through the ACA marketplace. The Society of
Behavioral Medicine (SBM) supports the USPSTF guideline for
the consideration of prostate cancer screening for high-risk men
between the ages of 55 and 69. SBM encourages policymakers
to include provisions for coverage of patient navigation services in
the ACA to facilitate shared decision-making between providers
and patients regarding screening.
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INTRODUCTION

Prostate cancer (PCa) is the second most common cancer
in men, only second to skin cancer [1]. In 2017, 161,360
new cases of prostate cancer occurred in the USA [1].
Men in the USA have an 11.2% lifetime risk of being
diagnosed with prostate cancer. Disparities in incidence
and mortality exist for African American (AA) men. AA
men carry a 70% greater risk of being diagnosed with
PCa compared to white men [1, 2] and are twice as likely
to die from PCa. Additionally, incidence of PCa among
AA men is much higher at younger ages as compared to
Whites [3]. Specifically, the incidence rate of PCa among

Implications

Practice: Patient Navigators should receive
training in risk assessment and providing shared
decision-making services to men at high risk for
prostate cancer considering screening.
Policy: Policymakers should include provisions
for coverage of patient navigation services in
the Affordable Care Act to facilitate shared
decision-making between providers and patients
regarding prostate cancer screening.
Research: Future research should be aimed
at barriers and facilitators to prostate cancer
screening among high-risk men.
AA men at ages 45–49 is identical to the incidence rate
among White men at ages 55–59 [4].
In 2018, the United States Preventive Services Task
Force (USPSTF) issued an updated recommendation
statement on serum Prostate Specific Antigen (PSA)based screening for PCa [5]. In 2012, the USPSTF
recommended against PSA-based screening for men
aged 55–69, concluding that any morbidity and mortality benefits were outweighed by harms related
to overdiagnosis and overtreatment resulting from
screening (e.g., anxiety from false positive tests, morbidity from treatment of indolent tumors) (D rating;
see Table 1). Following this recommendation, rates of
PSA screening declined substantially, among men in
all risk levels. In 2018, a new USPSTF panel revised
PSA screening to a C recommendation based mainly
on: (a) cumulative evidence that the previous analysis
had underestimated the mortality benefit and (b)
emerging evidence that active surveillance was a safe
option for men with low-risk cancer, which could thus
reduce harm due to overtreatment. The latest guideline recommends that care providers and men aged
55–69 engage in a shared decision process about
benefits and risks before PSA screening is started.
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Table 1 | USPSTF recommendation ratings

Grade

Definition

Suggestions for practice

A

The USPSTF recommends the service. There is high certainty
that the net benefit is substantial.
The USPSTF recommends the service. There is high certainty
that the net benefit is moderate or there is moderate
certainty that the net benefit is moderate to substantial.
The USPSTF recommends selectively offering or providing
this service to individual patients based on professional
judgment and patient preferences. There is at least
moderate certainty that the net benefit is small.
The USPSTF recommends against the service. There is
moderate or high certainty that the service has no net
benefit or that the harms outweigh the benefits.
The USPSTF concludes that the current evidence is
insufficient to assess the balance of benefits and harms
of the service. Evidence is lacking, of poor quality, or
conflicting, and the balance of benefits and harms cannot
be determined.

Offer or provide this service.

B

C

D

I Statement

While concluding that too few data were available to
definitively assess the relative benefits and harms, the
panel noted that decision analysis models indicated
that benefits could be greater for AA men, especially
if initiated before age 55. Furthermore, the latest
USPSTF panel encouraged clinicians to perform a
risk assessment and to inform AA men and those
with a positive family history about their increased
risk as part of shared decision-making.
POLICY GAPS

This new recommendation will require providers to
educate high-risk men on the benefits and harms of
PSA-based PCa screening so that they can make an
informed decision [5]. The ACA includes provisions
of service coverage for patient navigators who can
help patients decide whether screening is appropriate
given potential risks and benefits and training of
health care providers in shared decision regarding
screening/treatment. These services can be utilized
to support health care providers to better adhere
to the new guideline. However, recommendations
that are given a C rating or lower are not consistently
reimbursed through many plans, including those
offered through the ACA marketplace. Given that the
updated screening recommendation for high-risk men
was given a C rating, there are limitations in terms of
reimbursement for these essential services. Compared
to many other interventions, shared decision making
regarding PCa screening is a complex issue for patients,
especially for those who are high risk or may have
relatively low health literacy. Thus, care providers must
be given adequate time and reimbursement in order for
this C recommendation to be carried out effectively.
SUMMARY STATEMENT AND RECOMMENDATIONS

The updated recommendation for PCa screening
represents an important step toward addressing
TBM

Offer or provide this service.

Offer or provide this service for selected patients
depending on individual circumstances.

Discourage the use of this service.

Read the clinical considerations section of USPSTF
Recommendation Statement. If the service
is offered, patients should understand the
uncertainty about the balance of benefits and
harms.

continuing inequities in PCa that exist for high-risk
populations, including AA men and men with a
family history of PCa. However, if PCa screening is
deemed appropriate given risk factors, provider recommendation, and patient preference, patient navigation services and training should be reimbursed
through the ACA regardless of recommendation
rating.
SBM supports the updated USPSTF guideline
and proposes additional recommendations for policy
makers/legislators to better adhere to the new guideline:
RECOMMENDATIONS FOR POLICYMAKERS
1. Expand the provisions within the ACA that support the
use of patient navigators to ensure care coordination of
cancer screening and follow-up.
2. Expand the provisions within the ACA that support
training of health care providers (i.e., physicians, nurses,
physician assistants, patient navigators) in risk assessment
and shared decision-making with high-risk men.
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